UY35294A - SOLID PHARMACEUTICAL COMPOSITION FOR AGOMELATINE BUCAL ADMINISTRATION - Google Patents

SOLID PHARMACEUTICAL COMPOSITION FOR AGOMELATINE BUCAL ADMINISTRATION

Info

Publication number
UY35294A
UY35294A UY0001035294A UY35294A UY35294A UY 35294 A UY35294 A UY 35294A UY 0001035294 A UY0001035294 A UY 0001035294A UY 35294 A UY35294 A UY 35294A UY 35294 A UY35294 A UY 35294A
Authority
UY
Uruguay
Prior art keywords
agomelatine
pharmaceutical composition
solid pharmaceutical
bucal
administration
Prior art date
Application number
UY0001035294A
Other languages
Spanish (es)
Inventor
Jean-Manuel Pean
Genty Patrick
Rioult Fabien
Genissel Patrick
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of UY35294A publication Critical patent/UY35294A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

La invención tiene por objeto una composición farmacéutica bucal sólida que contiene agomelatina de stinada a una acción sistémica.The object of the invention is a solid oral pharmaceutical composition containing stina agomelatine at a systemic action.

UY0001035294A 2013-02-08 2014-01-30 SOLID PHARMACEUTICAL COMPOSITION FOR AGOMELATINE BUCAL ADMINISTRATION UY35294A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1351085A FR3001894A1 (en) 2013-02-08 2013-02-08 SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN

Publications (1)

Publication Number Publication Date
UY35294A true UY35294A (en) 2014-08-29

Family

ID=48289330

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035294A UY35294A (en) 2013-02-08 2014-01-30 SOLID PHARMACEUTICAL COMPOSITION FOR AGOMELATINE BUCAL ADMINISTRATION

Country Status (5)

Country Link
AR (1) AR095152A1 (en)
FR (1) FR3001894A1 (en)
TW (1) TW201434495A (en)
UY (1) UY35294A (en)
WO (1) WO2014122405A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023506545A (en) * 2019-12-20 2023-02-16 エルテーエス ローマン テラピー－ジステーメ アーゲー Transmucosal therapeutic system containing agomelatine

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (en) 1990-02-27 1993-12-31 Adir Cie NOVEL DERIVATIVES WITH NAPHTHALENIC STRUCTURE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ATE325120T1 (en) 2001-09-19 2006-06-15 Merck Patent Gmbh NEW USE OF SUBSTITUTED AMINOMETHYL CHROMANES
FR2834890B1 (en) * 2002-01-23 2004-02-27 Servier Lab ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF AGOMELATIN
AU2004308962A1 (en) * 2003-12-24 2005-07-14 Sepracor Inc. Melatonin combination therapy for improving sleep quality
US7498465B2 (en) * 2004-02-13 2009-03-03 Les Laboratoires Servier Process for the synthesis and crystalline form of agomelatine
FR2866335B1 (en) 2004-02-13 2006-05-26 Servier Lab NEW PROCESS FOR THE SYNTHESIS OF AGOMELATIN
FR2889522B1 (en) 2005-08-03 2007-12-28 Servier Lab NOVEL IV CRYSTALLINE FORM OF AGOMELATIN, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2889523B1 (en) 2005-08-03 2007-12-28 Servier Lab NOVEL CRYSTALLINE FORM V OF AGOMELATIN, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2889521B1 (en) 2005-08-03 2007-12-28 Servier Lab NOVEL CRYSTALLINE FORM III OF AGOMELATIN, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2894475B1 (en) * 2005-12-14 2008-05-16 Servier Lab ORODISPERSIBLE PHARMACEUTICAL COMPOSITION FOR OROMUCOSAL OR SUBLINGUAL ADMINISTRATION OF AGOMELATIN
CN101481321B (en) 2009-02-27 2012-04-18 上海医药工业研究院 Agomelatine halogen hydride complex and preparation thereof
CN101585779B (en) 2009-03-10 2014-04-02 上海医药工业研究院 New crystal form of Agomelatine, preparation method and use thereof
WO2011006387A1 (en) 2009-07-11 2011-01-20 浙江华海药业股份有限公司 Process for preparing agomelatine, crystals of agomelatine and preparing process thereof
CN101955440B (en) 2009-07-17 2014-04-09 江苏万特制药有限公司 Crystal form of agomelatine and preparation method thereof
CN102050755B (en) 2009-10-29 2014-11-05 重庆医药工业研究院有限责任公司 Novel agomelatine crystal forms and preparation methods of agomelatine crystal forms
CN102050756A (en) 2009-11-09 2011-05-11 北京利乐生制药科技有限公司 New crystal form of agomelatine and preparation method thereof
CN101781226B (en) 2009-12-23 2012-03-28 天津泰普药品科技发展有限公司 Agomelatine and medicine composition thereof
CN101774937B (en) 2010-02-05 2014-01-08 天津市汉康医药生物技术有限公司 N-[2-(7-methoxyl-1-naphthyl)ethyl]acetamide and compound thereof
JP4853600B2 (en) 2010-03-10 2012-01-11 パナソニック株式会社 Fuel cell system and power supply control system using the same
CN102190594A (en) 2010-03-17 2011-09-21 上海医药工业研究院 Agomelatine hydrogen chloride hydrate and preparation method thereof
CN101870662B (en) 2010-05-21 2013-03-20 中山大学 Crystalline Agomelatine solvate and preparation method thereof
WO2012046253A2 (en) 2010-10-08 2012-04-12 Msn Laboratories Limited Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms
CN102030673B (en) 2010-11-24 2014-04-23 威海迪素制药有限公司 New crystal form of agomelatine and preparation method thereof
CN102078309A (en) * 2011-01-22 2011-06-01 王定豪 Dispersible tablet containing antipsychotic medicines and application thereof
WO2012130837A1 (en) * 2011-03-28 2012-10-04 Ratiopharm Gmbh Solid agomelatine in non-crystalline form
CN102206864B (en) 2011-04-13 2012-10-03 吉林省博大伟业制药有限公司 Agomelatine monocrystal with agomelatine VI crystal form, agomelatine mixed crystal with the agomelatine VI crystal form and preparation methods
CN102885798B (en) * 2011-07-21 2015-04-22 成都康弘药业集团股份有限公司 Orally disintegrating tablet
CN102503886B (en) 2011-10-11 2013-09-11 中山大学 Agomelatine-isonicotine eutectic crystal and compound and preparation method thereof
CN102432490A (en) 2011-11-02 2012-05-02 江西施美制药有限公司 Agomelatine crystal form D and preparation method thereof

Also Published As

Publication number Publication date
TW201434495A (en) 2014-09-16
WO2014122405A1 (en) 2014-08-14
AR095152A1 (en) 2015-09-30
FR3001894A1 (en) 2014-08-15

Similar Documents

Publication Publication Date Title
BR112018005750A2 (en) oral hygiene compositions.
BR112016000489A2 (en) compound, pharmaceutical composition comprising it, use of the composition and methods for making compounds
CL2013003145A1 (en) Pharmaceutical formulation comprising mixture of anti-alpha4 beta7 antibody, an antioxidant or chelator and at least one free amino acid.
SV2017005601A (en) PHARMACEUTICAL FORMULATIONS CONTAINING TENOFOVIR AND EMTRICITABINE
CL2016000534A1 (en) Composition for oral care
BR112017012626A2 (en) oral hygiene instrument
BR112017012625A2 (en) oral hygiene instrument
BR112015030553A2 (en) device for the application of liquid medicinal substances
MA54716A (en) REDUCTION OF THE VISCOSITY OF PHARMACEUTICAL FORMULATIONS
BR112017010947A2 (en) oral hygiene instrument
BR112015031979A2 (en) letermovir, solid oral pharmaceutical formulation, use of a solid oral pharmaceutical formulation, and process for preparing letermovir.
CL2016000038A1 (en) Pyroxolo-substituted pyridinamines
BR112017017199A2 (en) oral hygiene instrument
BR112017022439A2 (en) oral hygiene compositions.
CL2019001038A1 (en) Composition for oral care.
BR112017010942A2 (en) oral hygiene instrument
MX2016006087A (en) Rapidly disintegrating formulations and methods of use.
BR112015023965A2 (en) composition for oral hygiene.
BR112017013158A2 (en) calcium and phosphate formulations for oral inflammation.
EA201691924A1 (en) PHARMACEUTICAL COMPOSITIONS
BR112017012636A2 (en) oral care compositions
CL2019001624A1 (en) Composition for oral care.
CL2019000323A1 (en) Composition for oral care.
UY35294A (en) SOLID PHARMACEUTICAL COMPOSITION FOR AGOMELATINE BUCAL ADMINISTRATION
CL2017001077A1 (en) Pharmaceutical compositions comprising lobeglitazone for oral administration

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20150714